Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-120221
Filing Date
2026-03-23
Accepted
2026-03-23 19:09:55
Documents
1
Period of Report
2026-03-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14824
  Complete submission text file 0001193125-26-120221.txt   16276
Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
FitzPatrick Margaret M (Reporting) CIK: 0001873879 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 26783804

Mailing Address 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025
Business Address 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)